Routine screening for prostate cancer with the prostate-specific antigen (PSA) test has come under fire in recent months, but what would happen if there was no such screening?

According to a new analysis, three times as many men would have advanced prostate cancer on diagnosis if there was no screening. The researchers suggest that PSA testing in the United States prevents about 17,000 men each year from having advanced metastatic prostate cancer at diagnosis.